Latest Breaking News On - Leidos biomedical research inc - Page 5 : comparemela.com

$40 million multi-year study to examine long-term impacts of COVID-19 and MIS-C

$40 million multi-year study to examine long-term impacts of COVID-19 and MIS-C Up to 2,000 children and young adults will be enrolled in a study from Children s National Hospital in collaboration with the National Institute of Allergy and Infectious Diseases (NIAID) that will examine the long-term effects of COVID-19 and multisystem inflammatory syndrome in children (MIS-C) after these patients have recovered from a COVID-19 infection. This $40 million multi-year study will provide important information about quality of life and social impact, in addition to a better understanding of the long-term physical impact of the virus, including effects on the heart and lung. The researchers hope to detail the role of genetics and the immune response to COVID19, so-called long COVID and MIS-C, including the duration of immune responses from SARS-CoV-2, the virus that causes COVID-19. It is fully funded by a subcontract with the NIH-funded Frederick National Laboratory for Cancer Research

Children's National Hospital and NIAID launch large study on long-term impacts of COVID-19 and ...

GenScript to Host Gene & Cell Engineering Virtual Summit

Genomic Data Commons offers the largest resource in cancer genomics

Genomic Data Commons provides unprecedented cancer data resource

 E-Mail The National Cancer Institute s Genomic Data Commons (GDC), launched in 2016 by then-Vice President Joseph Biden and hosted at the University of Chicago, has become one of the largest and most widely used resources in cancer genomics, with more than 3.3 petabytes of data from more than 65 projects and over 84,000 anonymized patient cases, serving more than 50,000 unique users each month. In new papers published Feb. 22 in Nature Genetics, the UChicago-based research team shares new details about the GDC, which is funded by the National Cancer Institute (NCI), via subcontract with the Frederick National Laboratory for Cancer Research, currently operated by Leidos Biomedical Research, Inc. One of the papers describes the design and operation of the GDC. The other describes the pipelines used by the GDC for the harmonization of data submitted to the GDC and the generation of datasets used by the GDC research community.